Amphastar Pharmaceuticals, Inc. Shares Issued
Amphastar Pharmaceuticals, Inc. (AMPH) had Shares Issued of 62.31 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 62.31M shares.
- 2026-03-31: Common Stock, Shares, Issued 62.13M shares.
- 2025-12-31: Common Stock, Shares, Issued 61.78M shares.
- 2025-09-30: Common Stock, Shares, Issued 61.68M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 62.31M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 62.13M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 61.78M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 61.68M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 61.65M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 61.29M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 60.85M shares 10-K · filed 2026-02-26 | |
| 2024-09-30 | 60.69M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 60.48M shares 10-Q · filed 2024-08-09 | |
| 2024-03-31 | 60.16M shares 10-Q · filed 2024-05-10 | |
| 2023-12-31 | 59.39M shares 10-K · filed 2025-03-03 | |
| 2023-09-30 | 59.22M shares 10-Q · filed 2023-11-08 | |
| 2023-06-30 | 59.07M shares 10-Q · filed 2023-08-09 | |
| 2023-03-31 | 58.44M shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 58.11M shares 10-K · filed 2024-02-29 | |
| 2022-09-30 | 57.99M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 57.90M shares 10-Q · filed 2022-08-09 | |
| 2022-03-31 | 57.50M shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 56.44M shares 10-K · filed 2023-03-01 | |
| 2021-09-30 | 56.05M shares 10-Q · filed 2021-11-09 | |
| 2021-06-30 | 55.74M shares 10-Q · filed 2021-08-09 | |
| 2021-03-31 | 55.18M shares 10-Q · filed 2021-05-07 | |
| 2020-12-31 | 54.76M shares 10-K · filed 2022-03-11 | |
| 2020-09-30 | 54.62M shares 10-Q · filed 2020-11-06 | |
| 2020-06-30 | 54.37M shares 10-Q · filed 2020-08-07 | |
| 2020-03-31 | 52.86M shares 10-Q · filed 2020-05-11 | |
| 2019-12-31 | 52.50M shares 10-K · filed 2021-03-15 | |
| 2019-09-30 | 52.40M shares 10-Q · filed 2019-11-08 | |
| 2019-06-30 | 52.21M shares 10-Q · filed 2019-08-09 | |
| 2019-03-31 | 52.04M shares 10-Q · filed 2019-05-10 | |
| 2018-12-31 | 51.44M shares 10-K · filed 2020-03-16 | |
| 2018-09-30 | 50.88M shares 10-Q · filed 2018-11-09 | |
| 2018-06-30 | 50.66M shares 10-Q · filed 2018-08-09 | |
| 2018-03-31 | 50.47M shares 10-Q · filed 2018-05-10 | |
| 2017-12-31 | 50.04M shares 10-K · filed 2019-03-15 | |
| 2017-09-30 | 48.99M shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 48.87M shares 10-Q · filed 2017-08-09 | |
| 2017-03-31 | 48.00M shares 10-Q · filed 2017-05-10 | |
| 2016-12-31 | 47.77M shares 10-K · filed 2018-03-14 | |
| 2016-09-30 | 47.51M shares 10-Q · filed 2016-11-09 | |
| 2016-06-30 | 46.52M shares 10-Q · filed 2016-08-09 | |
| 2016-03-31 | 46.10M shares 10-Q · filed 2016-05-10 | |
| 2015-12-31 | 45.96M shares 10-K · filed 2017-03-15 | |
| 2015-09-30 | 45.21M shares 10-Q · filed 2015-11-13 | |
| 2015-06-30 | 45.33M shares 10-Q · filed 2015-08-13 | |
| 2015-03-31 | 44.66M shares 10-Q · filed 2015-05-14 | |
| 2014-12-31 | 44.68M shares 10-K · filed 2016-03-15 | 44.65M shares 10-K · filed 2015-03-26 |
| 2014-09-30 | 44.65M shares 10-Q · filed 2014-11-13 | |
| 2014-06-30 | 44.64M shares 10-Q · filed 2014-08-13 | |
| 2013-12-31 | 38.77M shares 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |